Journal: Molecular imaging and biology
Article Title: Preclinical assessment of the effectiveness of magnetic resonance molecular imaging of extradomain-B fibronectin for detection and characterization of oral cancer
doi: 10.1007/s11307-020-01524-6
Figure Lengend Snippet: CNR analysis of contrast-enhanced tumors revealed (a) significant differential enhancement between CAL27, HSC3, and SCC4 tumors with MT218 in accordance with their EDB-FN expression, while (b) gadoteridol showed no difference in enhancement between the three models. Enhancement with MT218 was (c) generally lower than gadoteridol in CAL27 tumors, (d) generally higher than gadoteridol in HSC3 tumors, and (e) substantially higher than gadoteridol in SCC4 tumors. Maximum CNR enhancement in subjects with MT218 was (f) borderline lower than gadoteridol in CAL27 tumors (p=0.0957), (g) borderline higher than gadoteridol in HSC3 tumors (p=0.0639), and (h) significantly higher than gadoteridol in SCC4 tumors. (f-h) Open dots connected with a solid line represent matched mouse-by-mouse data, and solid dots connected with a dotted line represent cohort averages. (i) Average maximum CNR enhancement was significantly different between the three tumor models in accordance with their EDB-FN expression with MT218, but not with gadoteridol. Data was analyzed with Two-Way ANOVA and Fisher’s least significant difference post-hoc test (a-e,i) and unpaired T-tests (f-h) (*, p<0.05; **, p<0.01; ***, p<0.001; n.s., p>0.05).
Article Snippet: Cell culture Human OSCC cell lines CAL27 and SCC4 were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA).
Techniques: Expressing